Cordycepin (3′-deoxyadenosine), an inhibitor of mRNA polyadenylation, suppresses proliferation and activates apoptosis in human epithelial endometriotic cells in vitro

Gynecologic and Obstetric Investigation

Volumn 72, Issue 1, 2011, Pages 43-49

  Imesch, Patrick ^a   Hornung, René ^b   Fink, Daniel ^a   Fedier, André ^a  

^a UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Apoptosis; Cordycepin; Endometriosis; mRNA polyadenylation; Proliferation inhibition

Indexed keywords

CASPASE 3; CASPASE 9; CORDYCEPIN; CYCLIN D1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN P21; PROTEIN PRECURSOR; RETINOBLASTOMA PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DEOXYADENOSINE DERIVATIVE; POLYNUCLEOTIDE ADENYLYLTRANSFERASE;

APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; CELL CULTURE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN 11 Z; CELL SURVIVAL; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENDOMETRIOSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PERITONEUM CELL; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA PROCESSING; UPREGULATION; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

APOPTOSIS; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DEOXYADENOSINES; ENDOMETRIOSIS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; PHOSPHORYLATION; POLYADENYLATION; POLYNUCLEOTIDE ADENYLYLTRANSFERASE; RETINOBLASTOMA PROTEIN; RNA, MESSENGER;

EID: 80051782695     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000322395     Document Type: Article

References (32)

1. Valle RF, Sciarra JJ: Endometriosis: Treatment strategies. Ann NY Acad Sci 2003; 997: 229-239. (Pubitemid 38491079)
2. Olive DL, Lindheim SR, Pritts EA: New medical treatments for endometriosis. Best Pract Res Clin Obstet Gynaecol 2004; 18: 319-328. (Pubitemid 38786635)
3. Guo SW: Epigenetics of endometriosis. Mol Hum Reprod 2009; 15: 587-607.
4. Imesch P, Fink D, Fedier A: Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertil Steril 2010, E-pub ahead of print.
5. Nakamura K, Konoha K, Yoshikawa N, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M: Effect of cordycepin (3 β -deoxyadenosine) on hematogenic lung metastatic model mice. In Vivo 2005; 19: 137-141.
6. Nakamura K, Yoshikawa N, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M: Antitumor effect of cordycepin (3 β -deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Res 2006; 26: 43-47. (Pubitemid 43206058)
7. Wu WC, Hsiao JR, Lian YY, Lin CY, Huang BM: The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line. Cancer Chemother Pharmacol 2007; 60: 103-111.
8. Chang W, Lim S, Song H, Song BW, Kim HJ, Cha MJ, Sung JM, Kim TW, Hwang KC: Cordycepin inhibits vascular smooth muscle cell proliferation. Eur J Pharmacol 2008; 597: 64-69.
9. Chen LS, Stellrecht CM, Gandhi V: RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells. Br J Haematol 2008; 140: 682-691. (Pubitemid 351300913)
10. 2 /M cell-cycle arrest by regulating c-Jun Nterminal kinase activation in human bladder cancer cells. Arch Biochem Biophys 2009; 490: 103-109.
11. Müller WE, Seibert G, Beyer R, Breter HJ, Maidhof A, Zahn RK: Effect of cordycepin on nucleic acid metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme systems. Cancer Res 1977; 37: 3824-3833. (Pubitemid 8197916)
12. Penman S, Rosbash M, Penman M: Messenger and heterogeneous nuclear RNA in HeLa cells: Differential inhibition by cordycepin. Proc Natl Acad Sci USA 1970; 67: 1878-1885.
13. Wong YY, Moon A, Duffin R, Barthet-Barateig A, Meijer HA, Clemens MJ, de Moor CH: Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. J Biol Chem 2010; 285: 2610-2621.
14. Chen LS, Du-Cuny L, Vethantham V, Hawke DH, Manley JL, Zhang S, Gandhi V: Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analogues. Biochem Pharmacol 2010; 79: 669-677.
15. Scorilas A, Talieri M, Ardavanis A, Courtis N, Dimitriadis E, Yotis J, Tsiapalis CM, Trangas T: Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer. Cancer Res 2000; 60: 5427-5433.
16. Zeitvogel A, Baumann R, Starzinski-Powitz A: Identification of an invasive, N-cadherinexpressing epithelial cell type in endometriosis using a new cell culture model. Am J Pathol 2001; 159: 1839-1852. (Pubitemid 33062526)
17. Banu SK, Lee J, Starzinski-Powitz A, Arosh JA: Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells. Fertil Steril 2008; 90: 972-987.
18. Yoshino O, Osuga Y, Koga K, Hirota Y, Hirata T, Ruimeng X, Na L, Yano T, Tsutsumi O, Taketani Y: FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model. J Reprod Immunol 2006; 72: 85-93. (Pubitemid 44711877)
19. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A: The cyclins and cyclindependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 1999; 20: 501-534. (Pubitemid 30647078)
20. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-330.
21. Sherr CJ: Cancer cell cycles. Science 1996; 274: 1672-1677.
22. Giacinti C, Giordano A: RB and cell cycle progression. Oncogene 2006; 25: 5220-5527.
23. 1 protein expression in human endometriotic and adenomyotic lesions. Fertil Steril 2006; 85(suppl 1):1204-1207.
24. Agic A, Djalali S, Diedrich K, Hornung D: Apoptosis in endometriosis. Gynecol Obstet Invest 2009; 68: 217-223.
25. Danial NN, Korsmeyer SJ: Cell death: Critical control points. Cell 2004; 116: 205-219. (Pubitemid 38167313)
26. Riedl SJ, Salvesen GS: The apoptosome: Signalling platform of cell death. Nat Rev Mol Cell Biol 2007; 8: 405-413. (Pubitemid 46643237)
27. Jen CY, Lin CY, Leu SF, Huang BM: Cordycepin induced MA-10 mouse Leydig tumor cell apoptosis through caspase-9 pathway. Evid Based Complement Alternat Med 2009, E-pub ahead of print.
28. Cakmak H, Guzeloglu-Kayisli O, Kayisli UA, Arici A: Immune-endocrine interactions in endometriosis. Front Biosci (Elite Ed) 2009; 1: 429-443.
29. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911-1912. (Pubitemid 35425238)
30. 2 promotes cell proliferation in endometriosis by decreasing PTEN via NFkappaB- dependent pathway. Mol Cell Endocrinol 2010; 317: 31-43.
31. Seval Y, Cakmak H, Kayisli UA, Arici A: Estrogen- mediated regulation of p38 mitogenactivated protein kinase in human endometrium. J Clin Endocrinol Metab 2006; 91: 2349-2357. (Pubitemid 43855027)
32. Levchenko TS, Hartner WC, Verma DD, Bernstein EA, Torchilin VP: ATP-loaded liposomes for targeted treatment in models of myocardial ischemia. Methods Mol Biol 2010; 605: 361-375.